⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20276399 | 1.00 | — | — | |
| SCHEMBL20276345 | 1.00 | — | — | |
| SCHEMBL23945 | 0.86 | — | — | |
| SCHEMBL16645037 | 0.86 | — | — | |
| SCHEMBL15811675 | 0.83 | TSHR (0.33) | — | |
| SCHEMBL164617 | 0.81 | TSHR (0.32) | — | |
| SCHEMBL13898732 | 0.80 | TSHR (0.41) | — | |
| SCHEMBL535995 | 0.79 | TDP1 (0.33) | — | |
| SCHEMBL2954004 | 0.79 | TDP1 (0.33) | — | |
| SCHEMBL27981948 | 0.79 | TSHR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-12343324-B2 | Dihydromyricetin hot melt extrusion formulations and methods for forming them | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-07-01 | — | — | US | claimed |
| WO-2024254056-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | CATALENT ONTARIO LIMITED (CA) | 2024-12-12 | — | — | WO | claimed |
| CN-118201603-A | Multiparticulate pharmaceutical compositions | 神经中枢制药药物有限责任公司 | 2024-06-14 | — | — | CN | claimed |
| EP-4373473-A1 | MULTIPARTICULATE PHARMACEUTICAL COMPOSITION | Neuraxpharm Pharmaceuticals, S.L. (ES) | 2024-05-29 | — | — | EP | claimed |
| US-20230285352-A1 | Dihydromyricetin Hot Melt Extrusion Formulations and Methods for Forming Them | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2023-09-14 | — | — | US | claimed |
| WO-2023002004-A1 | MULTIPARTICULATE PHARMACEUTICAL COMPOSITION | LABORATORIOS LESVI, S.L. (ES) | 2023-01-26 | — | — | WO | claimed |
| US-20220280436-A1 | SOFTSHELL CAPSULE FORMULATIONS, AND METHODS OF PREPARATION AND USE THEREOF | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2022-09-08 | — | — | US | claimed |
| EP-4003310-A1 | SOFTSHELL CAPSULE FORMULATIONS, AND METHODS OF PREPARATION AND USE THEREOF | R.P. Scherer Technologies, LLC (US) | 2022-06-01 | — | — | EP | claimed |
| WO-2021016305-A1 | SOFTSHELL CAPSULE FORMULATIONS, AND METHODS OF PREPARATION AND USE THEREOF | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2021-01-28 | — | — | WO | claimed |
| US-20160067071-A1 | BIORESORBABLE BIOPOLYMER STENT | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-10 | — | — | US | claimed |
| WO-2015071394-A1 | FORMULATION OF SPARINGLY SOLUBLE COMPOUNDS BY HOT-MELT EXTRUSION | DSM IP ASSETS B.V. (NL) | 2015-05-21 | — | — | WO | claimed |
| WO-2014176451-A1 | BIORESORBABLE BIOPOLYMER STENT | TRUSTEES OF TUFTS COLLEGE (US) | 2014-10-30 | — | — | WO | claimed |
| US-7863316-B2 | Extended release formulation of Levetiracetam | UCB PHARMA S.A. (BE) | 2011-01-04 | — | — | US | claimed |
| US-20070110808-A1 | Extended release osmo-microsealed formulation | ALEMBIC LIMITED (IN) | 2007-05-17 | — | — | US | claimed |
| EP-1633330-B1 | EXTENDED RELEASE OSMO-MICROSEALED FORMULATION | ALEMBIC LTD (IN) | 2007-04-04 | — | — | EP | claimed |
| US-20030064101-A1 | Floating osmotic device for controlled release drug delivery | J.B. CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2003-04-03 | — | — | US | claimed |
| WO-2003026555-A2 | FLOATING OSMOTIC DEVICE FOR CONTROLLED RELEASE DRUG DELIVERY | J.B. CHEMICALS & PHARMACEUTICALS LTD. (IN) | 2003-04-03 | — | — | WO | claimed |
| EP-0062226-B1 | PROCESS FOR PREPARING WATER-DILUTABLE BINDER SOLUTIONS USING MONO-ALKYL-GLYCOL ETHERS | BASF Aktiengesellschaft (DE) | 1984-09-19 | — | — | EP | claimed |
| EP-0062226-A1 | Process for preparing water-dilutable binder solutions using mono-alkyl-glycol ethers | BASF Aktiengesellschaft (DE) | 1982-10-13 | — | — | EP | claimed |